Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
| Novartis Pharmaceuticals Corporation |
| Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd., MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, Mylan Pharmaceuticals Inc., Mylan Laboratories Limited, Viatris Inc. and Nanjing Noratech Pharmaceutical Co., Limited |
| 1:2022cv01395 |
| October 24, 2022 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 31, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 38
[SEALED] DECLARATION of Christopher E. Loh re #37 Answering Brief in Opposition, by Novartis Pharmaceuticals Corporation. (Attachments: #1 Certificate of Service)(Silver, Daniel) Modified on 12/22/2022 (nms).
|
|
Filing 37
[SEALED] ANSWERING BRIEF in Opposition re #26 MOTION to Dismiss for Failure to State a Claim filed by Novartis Pharmaceuticals Corporation.Reply Brief due date per Local Rules is 12/29/2022. (Attachments: #1 Certificate of Service)(Silver, Daniel)
|
|
SO ORDERED, re #36 MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang, filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/20/2022. (nms)
|
|
Filing 36
MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang - filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc.. (Weinblatt, Richard)
|
|
SO ORDERED, re #35 STIPULATION and Order to Extend Time to Respond to Complaint (*Reset Answer Deadlines: Mylan Laboratories Limited answer due 1/17/2023; Mylan Pharmaceuticals Inc. answer due 1/17/2023; Viatris Inc. answer due 1/17/2023). Signed by Judge Richard G. Andrews on 12/19/2022. (nms)
|
|
Filing 35
STIPULATION and Order to Extend Time to Respond to Complaint - filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Palapura, Bindu) Modified on 12/19/2022 (nms). Modified on 12/19/2022 (nms).
|
|
Filing 34
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Pvt. Ltd. for MSN Life Sciences Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc., MSN Pharmaceuticals Inc. filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc.. (Weinblatt, Richard)
|
|
Filing 33
ANSWER to #1 Complaint, and COUNTERCLAIMS against Novartis Pharmaceuticals Corporation, by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc., MSN Life Sciences Private Limited.(Weinblatt, Richard) Modified on 12/19/2022 (nms).
|
|
Filing 32
STIPULATION and Order to Extend Time - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd.. (Gattuso, Dominick) Modified on 12/14/2022 (nms).
|
|
SO ORDERED, re #32 STIPULATION and Order to Extend Time (*Reset Answer Deadlines: Crystal Pharmaceutical (Suzhou) Co., Ltd. answer due 1/16/2023). Signed by Judge Richard G. Andrews on 12/14/2022. (nms)
|
|
Pro Hac Vice Attorney Kyle C. Musgrove for Crystal Pharmaceutical (Suzhou) Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr)
|
|
Filing 31
REDACTED VERSION of #27 Opening Brief in Support, by Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Certificate of Service)(Gattuso, Dominick)
|
|
Filing 30
STIPULATION and Proposed Order to Extend Time - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 11/28/2022 (nms).
|
|
SO ORDERED, re #30 STIPULATION and Proposed Order to Extend Time to file redacted document to December 6, 2022. Signed by Judge Richard G. Andrews on 11/28/2022. (nms)
|
|
Filing 29
STIPULATION and Proposed Order to Extend Time - filed by Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Ormerod, Eve) Modified on 11/23/2022 (nms).
|
|
Filing 28
ORDER Granting Motion for Leave to File Under Seal (D.I. #25 ). Signed by Judge Richard G. Andrews on 11/23/2022. (nms)
|
|
SO ORDERED, re #29 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Alembic Global Holding SA answer due 1/16/2023; Alembic Pharmaceuticals Limited answer due 1/16/2023; Alembic Pharmaceuticals, Inc. answer due 1/16/2023). Signed by Judge Richard G. Andrews on 11/23/2022. (nms)
|
|
Filing 27
[SEALED] OPENING BRIEF in Support re #26 MOTION to Dismiss for Failure to State a Claim filed by Nanjing Noratech Pharmaceutical Co., Limited.Answering Brief/Response due date per Local Rules is 12/6/2022. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Certificate of Service)(Gattuso, Dominick)
|
|
Filing 26
MOTION to Dismiss for Failure to State a Claim - filed by Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: #1 Text of Proposed Order)(Gattuso, Dominick)
|
|
Filing 25
MOTION for Leave to File Under Seal - filed by Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: #1 Proposed Order, #2 Exhibit 1)(Gattuso, Dominick) Modified on 11/22/2022 (nms).
|
|
Filing 24
DECLARATION of Service of MSN Life Sciences Private Limited, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 11/21/2022 (nms).
|
|
Filing 23
DECLARATION of Service of MSN Laboratories Private Limited, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 11/21/2022 (nms).
|
|
SO ORDERED, re #22 MOTION for Pro Hac Vice Appearance of Attorney Scott A. Cunning II, C. Kyle Musgrove, and Elizabeth M. Crompton, each of the law firm of Parker Poe Adams & Bernstein, LLP, filed by Crystal Pharmaceutical (Suzhou) Co., Ltd.. Signed by Judge Richard G. Andrews on 11/21/2022. (nms)
|
|
Pro Hac Vice Attorney Elizabeth M. Crompton for Crystal Pharmaceutical (Suzhou) Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
|
|
Pro Hac Vice Attorney Don J. Mizerk for Nanjing Noratech Pharmaceutical Co., Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
|
|
Filing 22
MOTION for Pro Hac Vice Appearance of Attorney Scott A. Cunning II, C. Kyle Musgrove, and Elizabeth M. Crompton, each of the law firm of Parker Poe Adams & Bernstein, LLP - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd.. (Gattuso, Dominick)
|
|
Filing 21
MOTION for Pro Hac Vice Appearance of Attorney Don J. Mizerk and Matthew M. Kamps, each of the law firm of Husch Blackwell LLP - filed by Nanjing Noratech Pharmaceutical Co., Limited. (Gattuso, Dominick)
|
|
SO ORDERED, re #21 MOTION for Pro Hac Vice Appearance of Attorney Don J. Mizerk and Matthew M. Kamps, each of the law firm of Husch Blackwell LLP, filed by Nanjing Noratech Pharmaceutical Co., Limited. Signed by Judge Richard G. Andrews on 11/18/2022. (nms)
|
|
CORRECTING ENTRY: The docket text for D.I. #19 has been amended to reflect the correct filer of the stipulation. (nms)
|
|
SO ORDERED, re #19 STIPULATION and Order to Extend Time (*Reset Answer Deadlines: Nanjing Noratech Pharmaceutical Co., Limited answer due 12/22/2022). Signed by Judge Richard G. Andrews on 11/17/2022. (nms)
|
|
SO ORDERED, re #20 STIPULATION and Order to Extend Time to Respond to Complaint (*Reset Answer Deadlines: MSN Laboratories Private Limited answer due 12/16/2022; MSN Life Sciences Private Limited answer due 12/16/2022; MSN Pharmaceuticals Inc. answer due 12/16/2022). Signed by Judge Richard G. Andrews on 11/17/2022. (nms)
|
|
Filing 20
STIPULATION and Order to Extend Time to Respond to Complaint, filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc.. (Weinblatt, Richard) Modified on 11/17/2022 (nms).
|
|
Filing 19
STIPULATION and Order to Extend Time - filed by Nanjing Noratech Pharmaceutical Co.. (Gattuso, Dominick) Modified on 11/17/2022 (nms). Modified on 11/17/2022 (nms).
|
|
Filing 18
STIPULATION TO EXTEND TIME for Crystal to Answer the Complaint to December 16, 2022 - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd.. (Gattuso, Dominick)
|
|
Filing 17
DECLARATION of Service of Nanjing Noratech Pharmaceutical Co., Limited, by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibits A-B)(Joyce, Alexandra) Modified on 11/16/2022 (nms).
|
|
Filing 16
DECLARATION of Service of Mylan Pharmaceuticals Inc., by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 11/16/2022 (nms).
|
|
Filing 15
DECLARATION of Service of Mylan Laboratories Limited, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) Modified on 11/16/2022 (nms).
|
|
Filing 14
DECLARATION of Service of Crystal Pharmaceuticals (Suzhou) Co., Ltd., by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibits A-B)(Joyce, Alexandra) Modified on 11/16/2022 (nms).
|
|
Filing 13
DECLARATION of Service of Alembic Pharmaceuticals Limited, by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibits A-B)(Joyce, Alexandra) Modified on 11/16/2022 (nms).
|
|
Filing 12
DECLARATION of Service of Alembic Global Holding SA, by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibits A-B)(Joyce, Alexandra) Modified on 11/16/2022 (nms).
|
|
SO ORDERED, re #18 STIPULATION and Order to Extend Time (*Reset Answer Deadlines: Crystal Pharmaceutical (Suzhou) Co., Ltd. answer due 12/16/2022). Signed by Judge Richard G. Andrews on 11/16/2022. (nms)
|
|
SO ORDERED, re #11 STIPULATION and Order to Extend Time to Respond to Complaint (*Reset Answer Deadlines: Mylan Laboratories Limited answer due 12/16/2022; Mylan Pharmaceuticals Inc. answer due 12/16/2022; Viatris Inc. answer due 12/16/2022). Signed by Judge Richard G. Andrews on 11/14/2022. (nms)
|
|
Filing 11
STIPULATION and Order to Extend Time to Respond to Complaint - filed by Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Viatris Inc.. (Moore, David) Modified on 11/14/2022 (nms).
|
|
Pro Hac Vice Attorney Christopher E. Loh for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr)
|
|
Pro Hac Vice Attorney Nicholas N. Kallas,Christina Schwarz,Jared L. Stringham for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
|
|
Filing 10
MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Certifications for Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham)(Silver, Daniel)
|
|
SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham, filed by Novartis Pharmaceuticals Corporation. Signed by Judge Richard G. Andrews on 10/31/2022. (lah)
|
|
Filing 9
SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation.Viatris Inc. served on 10/27/2022, answer due 11/17/2022. (Joyce, Alexandra)
|
|
Filing 8
SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation.Mylan Laboratories Limited served on 10/27/2022, answer due 11/17/2022. (Joyce, Alexandra)
|
|
Filing 7
SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation.MSN Pharmaceuticals Inc. served on 10/27/2022, answer due 11/17/2022. (Joyce, Alexandra)
|
|
Filing 6
SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation.Alembic Pharmaceuticals, Inc. served on 10/27/2022, answer due 11/17/2022. (Joyce, Alexandra)
|
|
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (nms)
|
|
Filing 5
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (smg)
|
|
Filing 4
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,096,918. (smg)
|
|
Filing 3
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 11/08/2026. Stay Deadline: 7/7/2023. (smg)
|
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg)
|
|
Filing 1
COMPLAINT filed against Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., Nanjing Noratech Pharmaceutical Co., Limited, Viatris Inc. ( Filing fee $ 402, receipt number ADEDC-3989604.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(smg)
|
|
No Summons Issued. (smg)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
